Selective decontamination of the digestive tract as an infection-control measure in intensive care unit patientsOCCHIPINTI, D. J; ITOKAZU, G; DANZIGER, L. H et al.Pharmacotherapy. 1992, Vol 12, Num 6, pp 50S-63S, issn 0277-0008, 2Article

Frequency, pathogenicity and microbiologic outcome of non-Candida albicans candiduriaOCCHIPINTI, D. J; GUBBINS, P. O; SCHRECKENBERGER, P et al.European journal of clinical microbiology & infectious diseases (Print). 1994, Vol 13, Num 6, pp 459-467, issn 0934-9723Article

Therapeutic monitoring and pharmacist intervention in a Hansen's disease clinicPISCITELLI, S. C; OCCHIPINTI, D. J; DANZIGER, L. H et al.The Annals of pharmacotherapy. 1993, Vol 27, Num 12, pp 1526-1531, issn 1060-0280Article

Piperacillin/tazobactam : a new beta-lactam/beta-lactamase inhibitor combinationSCHOONOVER, L. L; OCCHIPINTI, D. J; RODVOLD, K. A et al.The Annals of pharmacotherapy. 1995, Vol 29, Num 5, pp 501-514, issn 1060-0280Article

Pharmacokinetics and pharmacodynamics of two multiple-dose piperacillin-tazobactam regimensOCCHIPINTI, D. J; PENDLAND, S. L; SCHOONOVER, L. L et al.Antimicrobial agents and chemotherapy. 1997, Vol 41, Num 11, pp 2511-2517, issn 0066-4804Article

Surveillance of treated and untreated funguria in a university hospitalGUBBINS, P. O; OCCHIPINTI, D. J; DANZIGER, L. H et al.Pharmacotherapy. 1994, Vol 14, Num 4, pp 463-470, issn 0277-0008Conference Paper